Tweedy, Browne Co’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Tweedy, Browne Co's JAZZ Position: Q3 2026 in Review
Tweedy, Browne Co reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.4% in Q3 2026, selling an estimated $215K and leaving 59,279 shares worth $13.7M. The position accounts for 1.12% of the portfolio, ranked #18.
Tweedy, Browne Co first reported a position in JAZZ in Q1 2026 and has held it in 3 quarters since. The position peaked at $14.5M in Q2 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Tweedy, Browne Co held 59,279 shares of Jazz Pharmaceuticals worth $13.7M as of Q3 2026.
- Tweedy, Browne Co sold 870 Jazz Pharmaceuticals shares in Q3 2026, an estimated $215K.
- Jazz Pharmaceuticals made up 1.12% of Tweedy, Browne Co's portfolio in Q3 2026, its #18 holding.
- Tweedy, Browne Co first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Tweedy, Browne Co's Jazz Pharmaceuticals position peaked at $14.5M in Q2 2026.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Tweedy, Browne Co's 13F filing for Q3 2026, filed 4 Nov 2026.